A pilot study of anlotinib with third-generation epidermal growth factor receptor tyrosine kinase inhibitors in untreated EGFR-mutant patients with advanced non-small cell lung cancer - Li, Ting; Chang, Kejie; Qiu, Xin; Lai, Zhirong; Luo, Yuanling; Chen, Jiaqun; Lv, Weize; Lin, Zhong; Pei, Xiaofeng; Wu, Xiangwen; Wang, Xiaojin (Translational Lung Cancer Research; Vol 12, No 6 (June 30, 2023): Translational Lung Cancer Research, 2023)